Treatment of colorectal carcinoma in adolescents and young adults with surgery, 5-fluorouracil/leucovorin/interferon-?2a and radiation therapy
β Scribed by Pratt, Charles B.; Rao, Bhaskar N.; Merchant, Thomas E.; Shah, Amit; Avery, Loraine; Cain, Aluida; Bodner, Sara; Poquette, Catherine; Tan, Ming
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 53 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
disease progression. IFN was administered subcutaneously three times weekly at for the Groupe d'Etude et de a dose of 3 MU (body surface area [BSA] Γ΅ 1.75 m 2 ) or 4.5 MU (BSA Β’ 1.75 m 2 ). Recherche sur les Cancers de RESULTS. World Health Organization toxicity Grade 3-4 occurred in 21 patients l'O
Chemotherapy has a limited impact on adenocarcinoma of the stomach. Although biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (LV) and interferon-β£ (IFN-β£) has improved the outcomes of patients with metastatic colorectal carcinoma compared with 5-FU alone, this approach has not been ext
initial entry of 34 patients. Cancer Center, University of Miami School of RESULTS. At a median follow-up of 41 months (range, 12-80 months), 44 patients Medicine, Miami, Florida. were alive with a projected median overall survival of 54 months. Grade 3/4 muco-2 Regional Cancer Center, Baptist Hosp